GLP-1s, SGLT2s, and Diabetes Barbie at ENDO 2025

Welcome back to Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives!In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, recapped highlights from the 2025 Endocrine Society annual meeting. They spotlighted advances, controversies, and ongoing unmet needs in type 1 diabetes care.00:00:00 Intro00:00:40 GLP-1 RAs in type 1 diabetes00:05:50 Tirzepatide in type 1 diabetes00:08:32 Cardioprotective therapies in type 1 diabetes00:12:17 Type 1 diabetes Barbie and public education